Differences in clinical findings, pathology, and outcomes between C3 glomerulonephritis and membranoproliferative

Yukihiko Kawasaki1, Syuto Kanno2, Atsushi Ono2

  • 1Department of Pediatrics, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan. kyuki@fmu.ac.jp.

Insights

Pediatric complement component C3 glomerulonephritis (C3GN) shows a worse prognosis and treatment response compared to immune-complex-mediated membranoproliferative glomerulonephritis (IC-MPGN). Differentiating these conditions is crucial for patient management.

Area of Science:

  • Nephrology
  • Pediatric Nephrology
  • Immunology

Background:

  • Distinguishing between C3 glomerulonephritis (C3GN) and immune-complex-mediated membranoproliferative glomerulonephritis (IC-MPGN) in pediatric patients is clinically significant.
  • Idiopathic MPGN encompasses both C3GN and IC-MPGN, necessitating clearer diagnostic criteria.

Purpose of the Study:

  • To compare the clinical manifestations, clinicopathological findings, and prognosis of pediatric C3GN and IC-MPGN.
  • To evaluate the utility of differentiating between C3GN and IC-MPGN for treatment and prognostic assessments.

Main Methods:

  • Retrospective analysis of 37 pediatric patients diagnosed with "idiopathic MPGN".
  • Patients were divided into two groups: 19 with IC-MPGN (Group 1) and 18 with C3GN (Group 2).
  • Comparison of clinical data, renal biopsy findings, and long-term outcomes between the two groups.

Main Results:

  • C3GN patients (Group 2) showed a higher incidence of urinary protein excretion, hematuria, low serum C3 levels, and more severe histological damage (mesangial proliferation, glomerular sclerosis, interstitial fibrosis) at follow-up biopsy.
  • Fewer C3GN patients presented with macro-hematuria or low serum C4 levels initially compared to IC-MPGN patients.
  • A greater proportion of C3GN patients experienced treatment non-response or progressed to end-stage renal disease.

Conclusions:

  • Pediatric C3GN is associated with a poorer treatment response and prognosis than IC-MPGN.
  • Classifying idiopathic MPGN into C3GN and IC-MPGN is valuable for guiding clinical treatment and predicting patient outcomes.
  • Long-term monitoring of pediatric C3GN patients is essential.
Abstract

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
950
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
8.6K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
927
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.4K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
597
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
628